Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Totalis/Universalis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Ended earlyNCT04517864
What this trial is testing

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Who this might be right for
Alopecia Areata
Pfizer 71
Large-scale testing (Phase 3)Active Not RecruitingNCT04006457
What this trial is testing

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 1,052
Not applicableStudy completedNCT07101471
What this trial is testing

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Who this might be right for
Alopecia Totalis/UniversalisAlopecia Areata(AA)
NanoAlvand 296
Large-scale testing (Phase 3)Study completedNCT03732807
What this trial is testing

PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 718
Large-scale testing (Phase 3)Study completedNCT00997815
What this trial is testing

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Who this might be right for
Recalcitrant Alopecia TotalisRecalcitrant Alopecia Universalis
Siriraj Hospital 20
Not applicableStudy completedNCT02312882
What this trial is testing

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Stanford University 40
Post-approval studies (Phase 4)Study completedNCT03800979
What this trial is testing

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Who this might be right for
Alopecia Areata
Institute of Dermatology, Thailand 19
Post-approval studies (Phase 4)Looking for participantsNCT07381556
What this trial is testing

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

Who this might be right for
Alopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more
Erasmus Medical Center 50
Testing effectiveness (Phase 2)UnknownNCT04011748
What this trial is testing

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Throne Biotechnologies Inc. 20
Not applicableActive Not RecruitingNCT00069589
What this trial is testing

Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+2 more
M.D. Anderson Cancer Center 3,100
Testing effectiveness (Phase 2)Study completedNCT03551821
What this trial is testing

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Aclaris Therapeutics, Inc. 1
Not applicableLooking for participantsNCT06283316
What this trial is testing

Systemic Treatments for Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+5 more
Erasmus Medical Center 10,000
Testing effectiveness (Phase 2)WithdrawnNCT03532958
What this trial is testing

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Equillium
Large-scale testing (Phase 3)Study completedNCT00063076
What this trial is testing

Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

Who this might be right for
Alopecia Areata
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT03594227
What this trial is testing

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Who this might be right for
Alopecia
Aclaris Therapeutics, Inc. 87
Large-scale testing (Phase 3)Study completedNCT06278402
What this trial is testing

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Jinnah Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02553330
What this trial is testing

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Who this might be right for
Alopecia Areata
Incyte Corporation 90
Testing effectiveness (Phase 2)WithdrawnNCT00746980
What this trial is testing

Efalizumab in the Treatment of Alopecia, Phase II

Who this might be right for
Alopecia Totalis
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT03359356
What this trial is testing

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Who this might be right for
Alopecia Areata
Icahn School of Medicine at Mount Sinai 60
Testing effectiveness (Phase 2)Ended earlyNCT03759340
What this trial is testing

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia AreataAlopecia UniversalisAlopecia Totalis
Aclaris Therapeutics, Inc. 56
Load More Results